Corpora amylacea in temporal lobe epilepsy associated with hippocampal sclerosis

Arquivos de Neuro-Psiquiatria

Volumn 61, Issue 4, 2003, Pages 942-945

  Ribeiro, Marlise De Castro ^a   Barbosa Coutinho, Lígia ^a   Mugnol, Fabiana ^a   Hilbig, Arlete ^a,b   Palmini, André ^a   Da Costa, Jaderson Costa ^a   Paglioli Neto, Eliseu ^a   Paglioli, Eduardo ^a  

^a PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

Corpora amylacea; Hippocampal sclerosis; Temporal lobe epilepsy

Indexed keywords

ADULT; AMYLOID BODY; AMYLOIDOSIS; ANALYSIS OF VARIANCE; ARTICLE; BRAIN SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; EPILEPSY; FEMALE; HIPPOCAMPAL SCLEROSIS; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; SCLEROSIS; STATISTICAL ANALYSIS; STUDENT T TEST; TEMPORAL LOBE EPILEPSY; TUKEY TEST;

EID: 0346993726     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2003000600010     Document Type: Article

References (18)

1. Babb TL, Brown WJ. Pathological findings in epilepsy. In Engel J Jr (ed), Surgical treatment of the epilepsies. New York: Raven Press, 1986,511-540.
2. Shingrao SK, Neal JW, Newman GR. Corpora amylacea could be indicator of degeneration. Neuropathol Appl Neurobiol 1993;19:269-276.
3. Cavanagh JB. Corpora amylacea and the family of polyglucosan diseases. Brain Res Rev 1999;29:265-295.
4. Chung MH, Horoupian DS. Corpora amylacea: a marker for mesial temporal sclerosis. J Neuropathol Exp Neurol 1996;55:403.
5. Loiseau H, Marchal C, Vital A, et al. Ocurrence of polyglucosan bodies in temporal lobe epilepsy. J Neurol Neurosurg psychiatry 1992;55:1092-1093.
6. Nishio S, Takato M, Tadao K, Kimiko F, Hiroki N, Matsushima M. Corpora amylacea replace the hipocampal pyramidal cell leyer in patient with temporal lobe epilepsy. Epilepsia 2001;42:960-962.
7. Graham D, Lantos P. Greenfield's neuropathology. 6.Ed., New York: Arnold 1997:1:124.
8. Botez G, Rami A. Imunorreactivity for Bcl-2 and C-Jun / AP1 in hipocampal corpora amylacea after ischaemia in humans. Neuropathol Appl Neurobiol 2001;27:474-478.
9. Erdamar S, Zhu ZQ, Hamilton WJ, et al. Corpora amylacea and heat shock protein 27 in Ammon's horn sclerosis. J Neuropathol Exp Neurol 2002;59:698-706.
10. Radhakrishnan VV, Bhaskara R, Radhakrishnan SV, et al. Pathology of temporal lobe epilepsy: an analysis of 100 consecutive surgical specimens from patients with medically refractory epilepsy. Neurology India 1999;47:1150-1157.
11. Barbosa-Coutinho LM, Hilbig A, Calcagnotto ME, et al. Neuropatologia das epilepsies de dificil controle: estudo de 300 casos consecutivos. Arq Neuropsiquiatr 1999;57:405-414.
12. Palmini A, da Costa JC, Paglioli-Neto E. How to select the best surgical strategy for patients with temporal lobe epilepsy. In Lüders H, Comair Y (eds). Epilepsy surgery 2.Ed. New York: Lippincott Raven, 2000:675-687.
13. Shingrao KSK, Morgan BP, Neal JW, Newman GR. A functional role for corpora amylacea based on evidence from complementary studies. Neurodegeneration 1995;4:335-345.
14. Shingrao SK, Neal JW, Piddleslen SJ, Newman GR. New immmunocytochemical evidence for a neuronal/oligodendroglial origin for corpora amylacea. Neuropathol Appl Neurobiol 1994;20:66-73.
15. Leal Õssyl. Corpora amylacea in hipocampal sclerosis (correspondence). J Neurol Neurosurg Psychiatry 1998;65:614.
16. Van Paesscchen W, Revesz T, Duncan JS. Corpora amylacea in hipocampal sclerosis. J Neurol Neurosurg Psychiatry 1997;63:513-515.
17. Gati I, Leel-Ossy L. Heat shock protein 60 in corpora amylacea. Pathol Oncol Res 2001;7:140-144.
18. Hoyaux D, Decaestecker C, Heizmann CW,et al. S100 proteins in corpora amylacea from normal human brain. Brain Res 2000;867:280-288.